The Use of a Combination Antibiogram to Assist with the Selection of Appropriate Antimicrobial Therapy for Carbapenemase-Producing Enterobacteriaceae Infections - PubMed (original) (raw)

. 2015 Dec;36(12):1458-60.

doi: 10.1017/ice.2015.196. Epub 2015 Aug 27.

Affiliations

• PMID: 26313707
• DOI: 10.1017/ice.2015.196

The Use of a Combination Antibiogram to Assist with the Selection of Appropriate Antimicrobial Therapy for Carbapenemase-Producing Enterobacteriaceae Infections

Alice J Hsu et al. Infect Control Hosp Epidemiol. 2015 Dec.

Abstract

Combination antibiograms can be used to evaluate organism cross-resistance among multiple antibiotics. As combination therapy is generally favored for the treatment of carbapenemase-producing Enterobacteriaceae (CPE), combination antibiograms provide valuable information about the combination of antibiotics that achieve the highest likelihood of adequate antibiotic coverage against CPE.

PubMed Disclaimer

Similar articles

• [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
  Cercenado E. Cercenado E. Rev Esp Quimioter. 2015 Sep;28 Suppl 1:8-11. Rev Esp Quimioter. 2015. PMID: 26365726 Review. Spanish.
• Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria.
  ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme. ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme. Euro Surveill. 2010 Nov 18;15(46):19719. doi: 10.2807/ese.15.46.19719-en. Euro Surveill. 2010. PMID: 21144433 No abstract available.
• [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
  Salgado P, Gilsanz F, Maseda E. Salgado P, et al. Rev Esp Quimioter. 2015 Sep;28 Suppl 1:12-5. Rev Esp Quimioter. 2015. PMID: 26365727 Review. Spanish.
• Over-treatment of carbapenemase-producing Enterobacteriaceae.
  Rihani DS, Wallace MR, Sieger BE, Waite RA, Fox M, Brown SA, Deryke CA. Rihani DS, et al. Scand J Infect Dis. 2012 May;44(5):325-9. doi: 10.3109/00365548.2011.638318. Epub 2011 Dec 27. Scand J Infect Dis. 2012. PMID: 22200121
• Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
  Hartl R, Widhalm S, Kerschner H, Apfalter P. Hartl R, et al. Clin Microbiol Infect. 2013 May;19(5):E230-2. doi: 10.1111/1469-0691.12146. Epub 2013 Feb 9. Clin Microbiol Infect. 2013. PMID: 23397897

Cited by

• Developmental roadmap for antimicrobial susceptibility testing systems.
  van Belkum A, Bachmann TT, Lüdke G, Lisby JG, Kahlmeter G, Mohess A, Becker K, Hays JP, Woodford N, Mitsakakis K, Moran-Gilad J, Vila J, Peter H, Rex JH, Dunne WM Jr; JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing. van Belkum A, et al. Nat Rev Microbiol. 2019 Jan;17(1):51-62. doi: 10.1038/s41579-018-0098-9. Nat Rev Microbiol. 2019. PMID: 30333569 Free PMC article. Review.
• Creation of a Combination Antibiogram for Pseudomonas aeruginosa in a Pediatric Intensive Care Unit.
  Thompson RZ, Sargel CL, Moore-Clingenpeel M, Karsies TJ. Thompson RZ, et al. J Pediatr Pharmacol Ther. 2021;26(8):828-833. doi: 10.5863/1551-6776-26.8.828. Epub 2021 Nov 10. J Pediatr Pharmacol Ther. 2021. PMID: 34790073 Free PMC article.
• Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.
  Garcinuño P, Santibañez M, Gimeno L, Sánchez-Bautista A, Coy J, Sánchez-Paya J, Boix V, Merino E, Portilla J, Rodríguez JC. Garcinuño P, et al. Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1851-1855. doi: 10.1007/s10096-016-2737-2. Epub 2016 Aug 9. Eur J Clin Microbiol Infect Dis. 2016. PMID: 27503076
• Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital.
  Scaglione V, Reale M, Davoli C, Mazzitelli M, Serapide F, Lionello R, La Gamba V, Fusco P, Bruni A, Procopio D, Garofalo E, Longhini F, Marascio N, Peronace C, Giancotti A, Gallo L, Matera G, Liberto MC, Cesana BM, Costa C, Trecarichi EM, Quirino A, Torti C. Scaglione V, et al. Microb Drug Resist. 2022 Apr;28(4):425-435. doi: 10.1089/mdr.2021.0109. Epub 2021 Dec 15. Microb Drug Resist. 2022. PMID: 34910885 Free PMC article.
• Biographical Feature: Karen C. Carroll, M.D.
  Munson E. Munson E. J Clin Microbiol. 2021 Jul 19;59(8):e0065121. doi: 10.1128/JCM.00651-21. Epub 2021 Jul 19. J Clin Microbiol. 2021. PMID: 33853837 Free PMC article. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Cambridge University Press
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal